A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
LONDON, ON – With newly announced studies, Lawson Health Research Institute continues to lead the way in advancing prostate cancer imaging. Scientists at Lawson are at the forefront of research that uses imaging agents that bind to a protein on the surface of prostate cancer cells called prostate...
A $125,000 grant from the Canadian Cancer Society will help create a database of PET/CT (positron emission tomography/computed tomography) and PET/MR (magnetic resonance) images of prostate cancer. The hope is that this database will be used to help improve diagnosis and treatment of men with...
Lawson Health Research Institute is the first in Canada to enter a sublicense agreement with The Centre for Probe Development and Commercialization (CPDC) to produce PSMA-1007, a new imaging agent that could help improve the detection of prostate cancer. The radiopharmaceutical tracer can locate and...
Scientists at Lawson Health Research Institute are leading the way in using specialized imaging to detect prostate cancer – the fifth leading cause of cancer death in men around the world.
In a newly published study, scientists at Lawson Health Research Institute have adapted PET/MRI technology to accurately image salt within the kidneys of patients with kidney disease.
LONDON, ON – In a newly published study, scientists at Lawson Health Research Institute have adapted PET/MRI technology to accurately image salt within the kidneys of patients with kidney disease. “Salt is very difficult to image in an MRI because the signal is much weaker than water,” explains Dr...
Researchers at Lawson Health Research Institute are collaborating with Canada’s largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), to study an innovative online program that offers older adults the opportunity to increase their knowledge of dementia...
LONDON, ON - Researchers at Lawson Health Research Institute are collaborating with Canada’s largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), to study an innovative online program that offers older adults the opportunity to increase their knowledge...
CHILDREN’S MENTAL HEALTH GRANT 2022 The Children’s Health Research Institute (CHRI) is pleased to announce the CHILDREN’S MENTAL HEALTH GRANT Competition for 2022 with funds generously provided by the Children’s Health Foundation (CHF). All CHRI Scientists and Associate Scientists conducting...
The COVID-19 pandemic has had a tangible impact on the mental health and wellbeing of Canadian health care workers, who have faced challenges that include increased workloads, resource constraints and fears of exposure to COVID-19. Announced today, researchers out of Lawson Health Research Institute...
CHILDREN’S MENTAL HEALTH GRANT 2022 The Children’s Health Research Institute (CHRI) is pleased to announce the CHILDREN’S MENTAL HEALTH GRANT Competition for 2022 with funds generously provided by the Children’s Health Foundation (CHF). All CHRI Scientists and Associate Scientists conducting...